A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals.
Antibodies, Monoclonal
/ chemistry
Biopharmaceutics
/ instrumentation
Biophysics
/ instrumentation
Circular Dichroism
/ methods
Immunoglobulin G
/ chemistry
Nuclear Magnetic Resonance, Biomolecular
/ methods
Protein Stability
Protein Structure, Secondary
Protein Structure, Tertiary
Sensitivity and Specificity
Spectrometry, Fluorescence
/ methods
Spectroscopy, Fourier Transform Infrared
/ methods
biopharmaceutical characterization
biophysical methods
biosimilarity
comparability
higher-order structure
monoclonal antibody
protein structure
secondary structure
tertiary structure
Journal
Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
08
08
2019
revised:
14
10
2019
accepted:
15
10
2019
pubmed:
2
11
2019
medline:
23
3
2021
entrez:
1
11
2019
Statut:
ppublish
Résumé
The higher-order structure (HOS) of protein therapeutics is a critical quality attribute directly related to their function. Traditionally, the HOS of protein therapeutics has been characterized by methods with low to medium structural resolution such as Fourier-transform infrared (FTIR), circular dichroism (CD), and intrinsic fluorescence spectroscopy, and differential scanning calorimetry (DSC). Recently, high-resolution nuclear magnetic resonance (NMR) methods have emerged as powerful tools for HOS characterization. NMR is a multi-attribute method with unique capabilities to provide information about all the structural levels of proteins in solution. We have in this study compared 1 D
Identifiants
pubmed: 31669605
pii: S0022-3549(19)30663-X
doi: 10.1016/j.xphs.2019.10.026
pii:
doi:
Substances chimiques
Antibodies, Monoclonal
0
Immunoglobulin G
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
247-253Informations de copyright
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.